177Lu-FAP-2286 Treatment in Urethelial Neoplasms: Utility and Safety as a Novel Treatment.

Clinical trial NCT06880757 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06880757
Sponsor: Ankara University
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Bladder (Urothelial, Transitional Cell) Cancer Metastatic or Unresectable

Start date: 2025-06-01
Primary completion: 2028-01-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.